Compare GRMN & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRMN | GEHC |
|---|---|---|
| Founded | 1990 | 1892 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7B | 38.9B |
| IPO Year | 2000 | N/A |
| Metric | GRMN | GEHC |
|---|---|---|
| Price | $199.30 | $82.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $236.00 | $89.08 |
| AVG Volume (30 Days) | 926.3K | ★ 3.8M |
| Earning Date | 02-18-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.75% | 0.17% |
| EPS Growth | 3.11 | ★ 4.84 |
| EPS | ★ 8.11 | 4.55 |
| Revenue | $6,943,125,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $15.77 | $5.90 |
| Revenue Next Year | $6.78 | $4.52 |
| P/E Ratio | $25.32 | ★ $18.16 |
| Revenue Growth | ★ 16.56 | 4.84 |
| 52 Week Low | $169.26 | $57.65 |
| 52 Week High | $261.69 | $94.80 |
| Indicator | GRMN | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 52.72 |
| Support Level | $198.27 | $78.23 |
| Resistance Level | $206.74 | $85.54 |
| Average True Range (ATR) | 5.15 | 2.13 |
| MACD | -0.69 | 0.04 |
| Stochastic Oscillator | 13.29 | 60.42 |
Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach. The company's product lines include smartwatches, fitness trackers, communication equipment, and a comprehensive suite of systems for marine and aviation navigation. Garmin operates globally, with its business focused primarily on North America and Europe.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).